Tennessee · House Bill 665 · 113th General Assembly

AN ACT to amend Tennessee Code Annotated, Title 53 and Title 63, relative to buprenorphine.

  1. Introduced Jan 26, 2023
  2. In committee Feb 1, 2023
  3. Died  
  4. Passed the Senate  
  5. To the governor  
  6. Became law  

What it does

The legislature's own summary of the bill, or its official long title.

Opioids - As introduced, prohibits a healthcare provider from prescribing a buprenorphine product unless the patient has first signed a copy of an informational document on the risks of buprenorphine use to pregnant women, unborn children, and infants; requires the department of health to make available on its public website the informational document within 90 days of the effective date of the act. - Amends TCA Title 53 and Title 63.

Every action

4 steps, oldest first, as the legislature records them.

  1. HouseFiled for introduction
  2. HouseIntro., P1C.
  3. CommitteeP2C, ref. to Health Committee · House Health Committee
  4. CommitteeAssigned to s/c Health Subcommittee · House Health Subcommittee

Roll calls

No recorded votes on this bill yet.

Sponsors

The member who introduced it.

  • TH Tim HicksR Primary sponsor · District 6

From Tennessee's official records (wapp.capitol.tn.gov), checked Nov 3, 2026. Text links go to the official versions; LegiList does not copy bill text.